| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 12/26/2006 | US7153850 Lactam compounds and pharmaceutical use thereof |
| 12/26/2006 | US7153847 Dipeptide-substituted benzo- and dibenzocaprolactams, which inhibit beta -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease |
| 12/26/2006 | US7153841 Conjugates with carriers; red shifted absorption; antiproliferative and antitumor agents; benign prostatic hyperplasia; diagnosis |
| 12/21/2006 | WO2006135824A1 Compounds that maintain pluripotency of embryonic stem cells |
| 12/21/2006 | WO2006135796A2 Crystalline forms of a pyrrolotriazine compound |
| 12/21/2006 | WO2006135687A1 Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists |
| 12/21/2006 | WO2006134318A1 Pyrazole-substituted benzimidazole derivatives for use in the treatment of cancer and autoimmune disorders |
| 12/21/2006 | WO2006133885A1 Tricyclic fused indole derivatives and their use as aurora kinase inhibitors |
| 12/21/2006 | WO2006089276A3 Pharmacokinetically improved compounds |
| 12/21/2006 | WO2006089275A3 Methods of making pharmacokinetically improved compounds comprising functional residues or groups and pharmaceutical compositions comprising said compounds |
| 12/21/2006 | WO2006088476A3 Carboranylporphyrins and uses thereof |
| 12/21/2006 | WO2005099712A3 Process for preparation of n-[3-(3-cyanopyrazolo [1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide |
| 12/21/2006 | WO2005047244A3 Inhibition of fgfr3 and treatment of multiple myeloma |
| 12/21/2006 | US20060287528 Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 12/21/2006 | US20060287526 Alkylating a 3-aminopyrazole-4-carbonitrile with a halo acetate, reacting with formamide or urea, or with the secondary nitrogen of a substituted or unsubstituted N-(2-aminoethyl)glycine moiety to cyclize and form 8-aza-7-deazaadenine base |
| 12/21/2006 | US20060287522 Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists |
| 12/21/2006 | US20060287520 Synthesis of salinosporamide A and analogues thereof |
| 12/21/2006 | US20060287379 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer |
| 12/21/2006 | US20060287360 Novel compounds |
| 12/21/2006 | US20060287342 Triazolopyrimidine heterocycles as cannabinoid receptor modulators |
| 12/21/2006 | US20060287341 2-substituted 7-aryl-[1,2,4]triazolo[4,3-c]pyrimidin-3(2H)-one; mitogen-activated protein kinase inhibitor; physiological and psychotropic effects including regulation of appetite, immunosuppression, analgesia, inflammation, emesis, anti-nocioception, sedation, and intraocular pressure |
| 12/21/2006 | US20060287340 e.g. 5-(4-fluorophenyl)-N-[2-(1-methyl-2-oxo-1,7-diazaspiro[4,4]nonan-7-yl)-6-quinolinyl]-2-pyrimidinecarboxamide; melanin concentrating hormone receptor antagonist; central nervous system disorders, cardiovascular disorders and metabolic disorders |
| 12/21/2006 | US20060287324 6-(2-Chlorophenyl)-7-(4-chlorophenyl)-N-cyclohexyl-[1,2,4]triazolo[4,3-b]pyridazin-3-amine; drug abuse, drug dependency; smoking cigarettes; appetite suppressants; antilipemic agents; anticholesterol agents; increasing high density lipoproteins;hypotensive agents; antidiabetic agents |
| 12/21/2006 | US20060287323 Regulation of appetite, antiemetics, immunosuppression, analgesia, inflammation, antinocioception, sedation, and intraocular pressure; synergistic; 2-(4-(Trifluoromethyl)benzyl)-7,8-bis(4-chlorophenyl)-6-(methylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one |
| 12/21/2006 | US20060287322 Bicyclic heterocycles as cannabinoind-1 receptor modulators |
| 12/21/2006 | US20060287321 Novel Lactam Derivatives |
| 12/21/2006 | US20060287310 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-butoxy]-3,4-dihydro-1H-[1,8]naphthyridin-2-one; use in the treatment of central nervous system disorders, bipolar disorder in a human; chemical synthesis |
| 12/21/2006 | US20060287309 [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
| 12/21/2006 | US20060287308 3-Aminoquinazolin-2,4-dione antibacterial agents |
| 12/21/2006 | US20060287296 Preparation of hymenialdsine derivatives and use thereof |
| 12/21/2006 | US20060287293 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 12/21/2006 | US20060287195 Novel materials for selective trapping of carbon minixide |
| 12/21/2006 | US20060286646 Stereoselective reduction process for the preparation of pyrrolotriazine compounds |
| 12/21/2006 | US20060286469 Imaging members |
| 12/21/2006 | US20060286468 Hydroxygallium phthalocyanines |
| 12/21/2006 | US20060286409 OLEDs doped with phosphorescent compounds |
| 12/21/2006 | US20060286043 Delivery of antihistamines through an inhalation route |
| 12/21/2006 | US20060286042 Condensation aerosol for delivery of a drug selected from the group consisting of zaleplon, zolpidem and zopiclone |
| 12/21/2006 | CA2611263A1 Crystalline forms of a pyrrolotriazine compound |
| 12/21/2006 | CA2610598A1 Compounds that maintain pluripotency of embryonic stem cells |
| 12/21/2006 | CA2609714A1 Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists |
| 12/20/2006 | EP1734041A2 Platelet ADP receptor inhibitors |
| 12/20/2006 | EP1733728A2 Use of 2-alkoxyphenyl substituted imidazotriazinones as inhibitors of phosphodiesterase |
| 12/20/2006 | EP1732933A1 Compounds and methods for treating dyslipidemia |
| 12/20/2006 | EP1732927A2 6-(2-fluorophenyl)-triazolopyrimidines, method for producing them, their use for controlling parasitic fungi and agents containing the same |
| 12/20/2006 | EP1732885A1 Lactams as conformationally constrained peptidomimetic inhibitors |
| 12/20/2006 | EP1732865A1 Fluoridation method |
| 12/20/2006 | EP1732541A2 Cyclic compounds |
| 12/20/2006 | EP1625131A4 Process and apparatus for preparing metal or nonmetal phthalocyanine |
| 12/20/2006 | EP1506200B1 Diazabicyclic biaryl derivatives |
| 12/20/2006 | EP1495025B1 Cyclic compounds and the use thereof as light absorbers or light emitters |
| 12/20/2006 | EP1392314B1 NOVEL USE OF 2-[2-Ethoxy-5-(4-methyl-piperazin-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-on |
| 12/20/2006 | EP1263729B1 Azacyclic compounds for use in the treatment of serotonin related diseases |
| 12/20/2006 | EP1147111B1 Cryptate compounds and methods for diagnosis and therapy |
| 12/20/2006 | EP0966442B1 Quinoline and quinazoline derivatives having corticotropin releasing factor (crf) antagonist activity |
| 12/20/2006 | CN1882591A 5,7-diaminopyrazolo '4,3-d!pyrimidines with pde-5 inhibiting activity |
| 12/20/2006 | CN1882590A Fused heterocyclic compounds as serotonin receptor modulators |
| 12/20/2006 | CN1882587A Use of tricyclic compounds as glycine transport inhibitors |
| 12/20/2006 | CN1882584A 4-substituted imidazoles |
| 12/20/2006 | CN1882583A 5-substituted imidazoles |
| 12/20/2006 | CN1882560A Heterocompound and its production and usage method |
| 12/20/2006 | CN1882551A Hexahydrodiazepinones as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 12/20/2006 | CN1880317A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 12/20/2006 | CN1880316A Method for producing folic acid antagonist and its intermediate |
| 12/20/2006 | CN1879617A Modulating multiple lineage kinase proteins |
| 12/20/2006 | CN1290848C Beta-amino tetrahydroimidazo (1,2-a) pyrazines and ahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/20/2006 | CN1290847C Aza-arylpiperazines |
| 12/19/2006 | US7151177 Process for the preparation of highly pure triethylene diamine |
| 12/19/2006 | US7151176 5-[(4-aminopiperidin-1-yl)methyl]-N-[(1R)-1-phenylethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine for example; antiproliferative agents; inhibit tyrosine kinase activity of growth factor receptors such as HER1, HER2 and HER4 |
| 12/19/2006 | US7151108 Anticarcinogenic, antiproliferative, and antitumor agents |
| 12/19/2006 | US7151105 Inhibitors of Hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 12/19/2006 | US7151102 Phthalazinone derivatives |
| 12/19/2006 | US7151097 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
| 12/14/2006 | WO2006132625A1 Composition for the vapor phase dehydrohalogenation of 1,1,2-trihaloethane to 1,1-dihaloethylene and methods for preparing and using such compositions |
| 12/14/2006 | WO2006132275A1 Prophylactic and/or therapeutic agent for motor disorder |
| 12/14/2006 | WO2006132197A1 HETEROCYCLIC COMPOUND HAVING TYPE I 11β HYDROXYSTEROID DEHYDROGENASE INHIBITORY ACTIVITY |
| 12/14/2006 | WO2006131835A2 Heterocyclic triazines as hypoxic selective protein kinase inhibitors |
| 12/14/2006 | WO2006131807A1 Preparation of 3-amino-4,5-disubstituted-pyrazole derivatives |
| 12/14/2006 | WO2006131192A1 New materials for organic electroluminescence devices |
| 12/14/2006 | WO2006116733A3 Protein kinase inhibitors |
| 12/14/2006 | WO2006105291A3 Heterocyclical chromophore architectures with novel electronic acceptor systems |
| 12/14/2006 | WO2006087120A3 Pyrazolopyrimidines |
| 12/14/2006 | WO2006014913A3 Inhibitors of 5'-methylthioadenosine phosphorylase and 5'methylthioadenosine/s-adenosylhomocysteine nucleosidase |
| 12/14/2006 | WO2005113555A8 Triazolopyrimidine compounds and their use for controlling pathogenic fungi |
| 12/14/2006 | US20060282038 Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine |
| 12/14/2006 | US20060281786 Compounds having activity at 5ht2c receptor and uses thereof |
| 12/14/2006 | US20060281767 Triazoloypyrimidines |
| 12/14/2006 | US20060281751 Raf inhibitor compounds and methods of use thereof |
| 12/14/2006 | US20060281746 neurokinin receptor 3 (NK3) antagonists; psychological disorders, inflammatory bowel disease, asthma, ischemia, Parkinson's disease; e.g. (1S,2R)-2-(4-Acetylamino-4-phenyl-piperidin-1-ylmethyl)-1-(3,4-dichlorophenyl)-cyclopropanecarboxylic acid, benzyl-methyl-amide |
| 12/14/2006 | US20060281733 4-Bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide; 5-(2-chlorobenzoylamino)-1H-pyrazole-3-carboxylic acid {2-[4-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]ethyl}amide; useful for the moderation of pain, septic shock, and scarring |
| 12/14/2006 | US20060281730 beta secretase inhibitors, used to treat cardiovascular diseases, cognitive and neurodegenerative diseases |
| 12/14/2006 | US20060281729 Macrocyclic heterocyclic aspartyl protease inhibitors |
| 12/14/2006 | US20060281727 (Cycloalkyleneiminocarbonyl)-indanyl- or -tetrahydronaphthyl- methylamines, e.g., {(1S)-1-[(1S)-5-(4-Fluorophenyl)-2,3-dihydro-1H-inden-1-yl]-2-[(3S)-3-fluoropyrrolidin-1-yl]-2-oxoethyl}amine hydrochloride; particularly for treating type 2 diabetes |
| 12/14/2006 | US20060281725 Agents and crystals for improving excretory potency of urinary bladder |
| 12/14/2006 | US20060281026 At least one ferrocenyl group bonded to a metallophthalocyanine dye through an anhydride group and a bridging unit; improved sensitivity, solubility, reflectivity, and recording performance |
| 12/14/2006 | US20060280692 A condensation aerosol for delivery of olanzapine by heating a compositionof olanzapine coated on a solid support to vaporize and condense; the vapor comprising particles of >10 percent by weight of olanzapine and <5 percent by weight of olanzapine degradation products; aerodynamic diameter=<5 microns |
| 12/14/2006 | DE19603377B4 Verfahren zur Herstellung von Cucurbituril A process for preparing cucurbituril |
| 12/14/2006 | CA2611312A1 Organic compounds |
| 12/13/2006 | EP1731520A1 Pyrrolo[2,3-d]pyrimidine derivatives which are antagonists of adenosine A1, A2A, and A3 |
| 12/13/2006 | EP1731519A1 Novel indole derivative for alkylating specific base sequence of dna and alkylating agent and drug each comprising the same |